.jpg "Matthew Riggs, PhD photo")
Chief Science Officer
Metrum Research Group
Dr. Riggs is Chief Science Officer at Metrum Research Group. He has been with MetrumRG for over 16 years. Matthew coordinates and connects the scientific operations of MetrumRG, through its research and scientific priorities, with MetrumRG’s mission and goals. He also leads research efforts to develop and integrate translational and systems pharmacology within model-driven therapeutics development.
Matthew received his B.S. in Pharmacy, Magna Cum Laude and with distinction, and Ph.D. degrees from the University of Connecticut School of Pharmacy. Following a post-doctoral fellowship at GloboMax LLC (now ICON Development Solutions), Matthew enjoyed nearly 5 years in Clinical Pharmacology at Pfizer Global Research and Development. While at MetrumRG, Matthew has served as an invited peer reviewer for several clinical pharmacology-related journals, included manuscript reviews for CP&T and CPT:PSP. He is a past-chair of the AAPS System Pharmacology Focus Group, the founding chair of the ASCPT Systems Pharmacology Community, and has served as a steering committee member of the ISoP QSP SIG and has been an active member on the QSP SIG's PMx/QSP Integration and QSP/Machine Learning Integration Working Groups. In 2019, he was the co-recipient of the International Society of Pharmacometrics (ISoP) Innovation Award and was also designated as an ISoP Fellow.
Disclosure information not submitted.
Friday, March 18, 2022
5:30 PM – 6:00 PM ET
.png)